Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Pharmaceutical Market: Saudi Arabia Industry Analysis and Opportunity Assessment, 2016-2026 - Prescription Products, Branded Drugs, Generic Drugs and OTC Products - Research and Markets

Research and Markets
Posted on: 13 Sep 16

Research and Markets has announced the addition of the "Pharmaceutical Market: Saudi Arabia Industry Analysis and Opportunity Assessment, 2016-2026" report to their offering.

This report offers a 10-year forecast of the Saudi Arabia pharmaceutical market between 2016 and 2026. In terms of value, the market is expected to register a CAGR of 9.0% over the forecast period. This study demonstrates market dynamics and trends that influence the current environment and future status of the pharmaceutical market in Saudi Arabia over the forecast period.

The report examines Saudi Arabia pharmaceutical market for the period 2016-2026. The primary objective of the report is to offer insights on various products such as prescription products, branded drugs, generic drugs and over-the-counter (OTC) products.

The report begins by defining various economic and healthcare indicators in the country, followed by an overview of dynamics of the Saudi Arabia pharmaceutical market, which includes analysis of key trends, drivers, restraints and opportunities and key players. It also includes insights into key regulations and reimbursement scenario. Impact analyses of key growth drivers and restraints based on the weighted average model have also been included in the report to better equip readers with meaningful insights on ongoing developments in the market.

Primary factors fuelling growth of the Saudi Arabia pharmaceutical market include increasing population and expatriates coupled with rapidly increasing healthcare infrastructure and proactive measures by the government to improve the healthcare systems in the country. Other factors driving demand for pharmaceuticals in Saudi Arabia are rising prevalence of lifestyle diseases and availability of better quality products from multinational companies.

Report Scope

Key Segments

- Product Type

- Prescription Products

- Branded Drugs

- Generic Drugs

- Over The Counter (OTC) Products

Disease Type

- Cardiovascular Diseases

- Diabetes

- Cancer

- Obesity

- Infectious Diseases

- Other Diseases

Distribution Channel

- Hospital Pharmacies

- Retail Pharmacies

Key Companies


- Tabuk Pharmaceuticals Manufacturing Co.

- Julphar

- Jamjoom Pharma

- Glaxosmithkline plc.

- Pfizer Inc.

- Novartis AG

- Sanofi

Key Topics Covered:

1. Research Methodology

2. Assumptions & Acronyms

3. Executive Summary

4. Saudi Arabia Pharmaceutical Market Overview

5. Saudi Arabia Pharmaceutical Market-Healthcare Indicators

6. Market Dynamics

7. Saudi Arabia Pharmaceuticals Market, By Product Type

8. Saudi Arabia Pharmaceuticals Market, By Disease Type

9. Saudi Arabia Pharmaceuticals Market, By Distribution Channel

10. Competition Landscape

For more information about this report visit

Related Topics: Pharmaceuticals

View source version on

Business Wire

Last updated on: 13/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.